Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AEGERION PHARMA (NQ: AEGR)
61.57 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News
Press releases about AEGERION PHARMA
 
< Previous 1 2 3 Next >
Free Research Reports on AEGR, DHI, SOL and WMT Issued by the Paragon Report
May 17, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
May 03, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Announces Presentation at the Bank of America Merrill Lynch 2013 Healthcare Conference
May 03, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Announces First-Quarter 2013 Financial Results
April 30, 2013
Commercial Launch of JUXTAPID(TM) (lomitapide) Capsules is on Track Read More
from GlobeNewswire News Releases
Anne VanLent Appointed to Aegerion Pharmaceuticals' Board of Directors
April 29, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Announces Presentation at the Needham Healthcare Conference
April 25, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals to Announce First Quarter 2013 Financial Results on Tuesday, April 30
April 16, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
April 03, 2013
from GlobeNewswire News Releases
News& Reports On: (NASDAQ: AEGR), (NYSE: CBI)
March 29, 2013
from SBWire Direct - Latest Press Releases
A forward Look into the Year Ahead - Research Report on Boyd Gaming Corporation, Ameristar Casinos, Inc., Aegerion Pharmaceuticals, Inc., ISIS Pharmaceuticals, Inc. and Avon Products, Inc.
March 12, 2013
from PR Newswire
FDA Programs Designed to Speed Up Approval Process Helps Send Drug Approvals to a 15-Year High in 2012
March 11, 2013
Five Star Equities Provides Stock Research on Aegerion Pharmaceuticals and Alnylam Read More
from Marketwired News Releases
Aegerion Pharmaceuticals Announces Fourth-Quarter and Year-End 2012 Financial Results
March 06, 2013
Promising Early Progress in Commercial Launch of JUXTAPID(TM) (lomitapide) Capsules Read More
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
March 05, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Observes Rare Disease Day
February 28, 2013
Company Joins NORD, EURORDIS, CORD and Others Worldwide in Supporting Awareness of Rare Diseases Read More
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Announces Presentation at the Cowen and Company 33rd Annual Health Care Conference
February 27, 2013
from GlobeNewswire News Releases
Tomorrow's Outlook in Today's Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
February 21, 2013
from PR Newswire
Aegerion Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on Wednesday, March 6
February 20, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcoming Conferences
February 07, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
February 07, 2013
from GlobeNewswire News Releases
FDA Approved a Total of 39 New Drugs in 2012 -- Fifteen Year High
February 01, 2013
Research Driven Investing Provides Stocks Research on Aegerion and Vertex Read More
from Marketwired News Releases
Free Research Reports on AEGR, CENX, KBR and WSO Issued by the Bedford Report
January 14, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
The Real Story Behind AEGR, GNMK, ENOC and WPI
January 14, 2013
from Marketwired News Releases
Aegerion Pharmaceuticals Prices Public Offering of Common Stock
January 11, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Announces Proposed Public Offering of Common Stock
January 10, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Announces Key Business and Financial Objectives for 2013 as the Company Prepares for U.S. Launch of JUXTAPID(TM) (lomitapide) Capsules
January 07, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
January 04, 2013
from GlobeNewswire News Releases
Aegerion Pharmaceuticals Announces Presentation at the 31st Annual J.P. Morgan Healthcare Conference
January 03, 2013
from GlobeNewswire News Releases
FDA Approves Aegerion Pharmaceuticals' JUXTAPID(TM) (lomitapide) Capsules for Homozygous Familial Hypercholesterolemia (HoFH)
December 24, 2012
from GlobeNewswire News Releases
LPX, LYG, BC and AEGR Freshly Hit a New 52-Week High
December 20, 2012
from Marketwired News Releases
Aegerion Pharmaceuticals Reserves Shares for Inducement Stock Options
December 06, 2012
from GlobeNewswire News Releases
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here